{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:03:25Z","timestamp":1740107005391,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2021KY094","2022RC114"],"award-info":[{"award-number":["2021KY094","2022RC114"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00432-023-04615-3","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T20:02:27Z","timestamp":1678996947000},"page":"7341-7353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pretherapy investigations using highly robust visualized biomarkers from CT imaging by multiple machine-learning techniques toward its prognosis prediction for ALK-inhibitor therapy in NSCLC: a feasibility study"],"prefix":"10.1007","volume":"149","author":[{"given":"Jingjing","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiantao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianglan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chencui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengbo","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"issue":"18","key":"4615_CR1","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.2217\/fon-2016-0163","volume":"12","author":"S Atagi","year":"2016","unstructured":"Atagi S et al (2016) Erlotinib for Japanese patients with activating EGFR mutation-positive non-small-cell lung cancer: combined analyses from two Phase II studies. Future Oncol 12(18):2117\u20132126. https:\/\/doi.org\/10.2217\/fon-2016-0163","journal-title":"Future Oncol"},{"key":"4615_CR2","doi-asserted-by":"publisher","first-page":"109710","DOI":"10.1016\/j.ejrad.2021.109710","volume":"139","author":"J Choe","year":"2021","unstructured":"Choe J et al (2021) CT radiomics-based prediction of anaplastic lymphoma kinase and epidermal growth factor receptor mutations in lung adenocarcinoma. Eur J Radiol 139:109710. https:\/\/doi.org\/10.1016\/j.ejrad.2021.109710","journal-title":"Eur J Radiol"},{"issue":"5","key":"4615_CR3","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/ije\/dyw145","volume":"45","author":"S Dietrich","year":"2016","unstructured":"Dietrich S et al (2016) Random Survival Forest in practice: a method for modelling complex metabolomics data in time to event analysis. Int J Epidemiol 45(5):1406\u20131420. https:\/\/doi.org\/10.1093\/ije\/dyw145","journal-title":"Int J Epidemiol"},{"issue":"11","key":"4615_CR4","doi-asserted-by":"publisher","first-page":"e0206108","DOI":"10.1371\/journal.pone.0206108","volume":"13","author":"TH Dou","year":"2018","unstructured":"Dou TH et al (2018) Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC. PLoS One 13(11):e0206108. https:\/\/doi.org\/10.1371\/journal.pone.0206108","journal-title":"PLoS One"},{"issue":"359","key":"4615_CR5","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/01621459.1977.10480613","volume":"72","author":"B Efron","year":"1977","unstructured":"Efron B (1977) The efficiency of Cox\u2019s likelihood function for censored data. J Am Stat Assoc 72(359):557\u2013565. https:\/\/doi.org\/10.1080\/01621459.1977.10480613","journal-title":"J Am Stat Assoc"},{"issue":"17\u201318","key":"4615_CR6","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1002\/(sici)1097-0258(19990915\/30)18:17\/18<2529::aid-sim274>3.0.co;2-5","volume":"18","author":"E Graf","year":"1999","unstructured":"Graf E et al (1999) Assessment and comparison of prognostic classification schemes for survival data. Stat Med 18(17\u201318):2529\u20132545. https:\/\/doi.org\/10.1002\/(sici)1097-0258(19990915\/30)18:17\/18%3c2529::aid-sim274%3e3.0.co;2-5","journal-title":"Stat Med"},{"issue":"15","key":"4615_CR7","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1158\/1078-0432.CCR-13-0318","volume":"19","author":"JF Gainor","year":"2013","unstructured":"Gainor JF et al (2013) ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer. Clin Cancer Res 19(15):4273\u20134281. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0318","journal-title":"Clin Cancer Res"},{"key":"4615_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/cjs.10046","volume":"38","author":"H Hung","year":"2009","unstructured":"Hung H, Chiang CT (2009) Estimation methods for time-dependent AUC models with survival data. Can J Stat 38:8\u201326. https:\/\/doi.org\/10.1002\/cjs.10046","journal-title":"Can J Stat"},{"issue":"10","key":"4615_CR9","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s10654-018-0434-4","volume":"33","author":"JA Hanley","year":"2018","unstructured":"Hanley JA (2018) Individually-matched etiologic studies: classical estimators made new again. Eur J Epidemiol 33(10):897\u2013907. https:\/\/doi.org\/10.1007\/s10654-018-0434-4","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"4615_CR10","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1186\/s12885-018-5136-5","volume":"18","author":"Y Huang","year":"2018","unstructured":"Huang Y et al (2018) The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis. BMC Cancer 18(1):1235. https:\/\/doi.org\/10.1186\/s12885-018-5136-5","journal-title":"BMC Cancer"},{"issue":"17","key":"4615_CR11","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1111\/1759-7714.14083","volume":"12","author":"D Hou","year":"2021","unstructured":"Hou D et al (2021) Association of anaplastic lymphoma kinase variants and alterations with ensartinib response duration in non-small cell lung cancer. Thorac Cancer 12(17):2388\u20132399. https:\/\/doi.org\/10.1111\/1759-7714.14083","journal-title":"Thorac Cancer"},{"key":"4615_CR12","doi-asserted-by":"publisher","unstructured":"Isaka T et al (2021)\u00a0Effect of epidermal growth factor receptor gene mutation on the prognosis of pathological stage II-IIIA (8th edition TNM classification) primary lung cancer after curative surgery. Lung Cancer 162:128\u2013134. https:\/\/doi.org\/10.1016\/j.lungcan.2021.11.002","DOI":"10.1016\/j.lungcan.2021.11.002"},{"issue":"18","key":"4615_CR13","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","volume":"363","author":"EL Kwak","year":"2010","unstructured":"Kwak EL et al (2010) Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 363(18):1693\u20131703. https:\/\/doi.org\/10.1056\/NEJMoa1006448","journal-title":"N Engl J Med"},{"issue":"6","key":"4615_CR14","doi-asserted-by":"publisher","first-page":"e449","DOI":"10.1016\/j.cllc.2017.05.011","volume":"18","author":"R Kato","year":"2017","unstructured":"Kato R et al (2017) Prognostic impact of minimal pericardial effusion in patients with advanced non-small-cell lung cancer. Clin Lung Cancer 18(6):e449\u2013e455. https:\/\/doi.org\/10.1016\/j.cllc.2017.05.011","journal-title":"Clin Lung Cancer"},{"issue":"19","key":"4615_CR15","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.3390\/cancers13194976","volume":"13","author":"G Karami","year":"2021","unstructured":"Karami G et al (2021) Predicting overall survival time in glioblastoma patients using gradient boosting machines algorithm and recursive feature elimination technique. Cancers (Basel) 13(19):4976. https:\/\/doi.org\/10.3390\/cancers13194976","journal-title":"Cancers (Basel)"},{"issue":"2","key":"4615_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/CJI.0000000000000396","volume":"45","author":"M Karayama","year":"2021","unstructured":"Karayama M et al (2021) Association of the geriatric nutritional risk index with the survival of patients with non-small cell lung cancer after nivolumab therapy. J Immunother 45(2):125\u2013131. https:\/\/doi.org\/10.1097\/CJI.0000000000000396","journal-title":"J Immunother"},{"key":"4615_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fonc.2020.00057","volume":"10","author":"H Li","year":"2020","unstructured":"Li H et al (2020) CT-based radiomic signature as a prognostic factor in stage IV ALK-positive non-small-cell lung cancer treated with TKI crizotinib: a proof-of-concept study. Front Oncol 10:57. https:\/\/doi.org\/10.3389\/fonc.2020.00057","journal-title":"Front Oncol"},{"issue":"9","key":"4615_CR18","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.21037\/qims-19-921","volume":"10","author":"Y Li","year":"2020","unstructured":"Li Y et al (2020) Influence of feature calculating parameters on the reproducibility of CT radiomic features: a thoracic phantom study. Quant Imaging Med Surg 10(9):1775\u20131785. https:\/\/doi.org\/10.21037\/qims-19-921","journal-title":"Quant Imaging Med Surg"},{"issue":"5","key":"4615_CR19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cllc.2012.01.004","volume":"13","author":"AL Moreira","year":"2012","unstructured":"Moreira AL, Thornton RH (2012) Personalized medicine for non-small-cell lung cancer: implications of recent advances in tissue acquisition for molecular and histologic testing. Clin Lung Cancer 13(5):334\u2013339. https:\/\/doi.org\/10.1016\/j.cllc.2012.01.004","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"4615_CR20","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/JTO.0b013e318164545d","volume":"3","author":"SH Ou","year":"2008","unstructured":"Ou SH, Zell JA (2008) Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry. J Thorac Oncol 3(3):216\u2013227. https:\/\/doi.org\/10.1097\/JTO.0b013e318164545d","journal-title":"J Thorac Oncol"},{"issue":"9","key":"4615_CR21","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1704795","volume":"377","author":"S Peters","year":"2017","unstructured":"Peters S et al (2017) Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer. N Engl J Med 377(9):829\u2013838. https:\/\/doi.org\/10.1056\/NEJMoa1704795","journal-title":"N Engl J Med"},{"issue":"212","key":"4615_CR22","first-page":"1","volume":"21","author":"S P\u00f6lsterl","year":"2020","unstructured":"P\u00f6lsterl S (2020) Scikit-Survival: A library for time-to-event analysis built on top of scikit-Learn. J Mach Learn Res 21(212):1\u20136","journal-title":"J Mach Learn Res"},{"issue":"23","key":"4615_CR23","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMoa1408440","volume":"371","author":"BJ Solomon","year":"2014","unstructured":"Solomon BJ et al (2014) First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med 371(23):2167\u20132177. https:\/\/doi.org\/10.1056\/NEJMoa1408440","journal-title":"N Engl J Med"},{"issue":"11","key":"4615_CR24","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1002\/mp.13202","volume":"45","author":"M Soufi","year":"2018","unstructured":"Soufi M, Arimura H, Nagami N (2018) Identification of optimal mother wavelets in survival prediction of lung cancer patients using wavelet decomposition-based radiomic features. Med Phys 45(11):5116\u20135128. https:\/\/doi.org\/10.1002\/mp.13202","journal-title":"Med Phys"},{"key":"4615_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fonc.2020.00369","volume":"10","author":"L Song","year":"2020","unstructured":"Song L et al (2020) Clinical, conventional CT and radiomic feature-based machine learning models for predicting ALK rearrangement status in lung adenocarcinoma patients. Front Oncol 10:369. https:\/\/doi.org\/10.3389\/fonc.2020.00369","journal-title":"Front Oncol"},{"issue":"2","key":"4615_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00259-020-04986-6","volume":"48","author":"Z Song","year":"2021","unstructured":"Song Z et al (2021) The deep learning model combining CT image and clinicopathological information for predicting ALK fusion status and response to ALK-TKI therapy in non-small cell lung cancer patients. Eur J Nucl Med Mol Imaging 48(2):361\u2013371. https:\/\/doi.org\/10.1007\/s00259-020-04986-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4615_CR27","doi-asserted-by":"publisher","first-page":"719919","DOI":"10.3389\/fonc.2021.719919","volume":"11","author":"X Tang","year":"2021","unstructured":"Tang X et al (2021) Machine learning-based CT radiomics analysis for prognostic prediction in metastatic non-small cell lung cancer patients with EGFR-T790M mutation receiving third-generation EGFR-TKI osimertinib treatment. Front Oncol 11:719919. https:\/\/doi.org\/10.3389\/fonc.2021.719919","journal-title":"Front Oncol"},{"issue":"5","key":"4615_CR28","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1053\/j.jvca.2021.08.029","volume":"36","author":"M Taylor","year":"2022","unstructured":"Taylor M et al (2022) Preoperative anemia is associated with worse long-term Survival after lung cancer resection: a multicenter cohort study of 5,029 patients. J Cardiothorac Vasc Anesth 36(5):1373\u20131379. https:\/\/doi.org\/10.1053\/j.jvca.2021.08.029","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"478","key":"4615_CR29","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1198\/016214507000000149","volume":"102","author":"H Uno","year":"2007","unstructured":"Uno H et al (2007) Evaluating prediction rules for t-year survivors with censored regression models. J Am Stat Assoc 102(478):527\u2013537. https:\/\/doi.org\/10.1198\/016214507000000149","journal-title":"J Am Stat Assoc"},{"issue":"21","key":"4615_CR30","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen JJM et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77(21):e104\u2013e107. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0339","journal-title":"Cancer Res"},{"issue":"7","key":"4615_CR31","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1007\/s00330-017-5221-1","volume":"28","author":"X Zhu","year":"2018","unstructured":"Zhu X et al (2018) Radiomic signature as a diagnostic factor for histologic subtype classification of non-small cell lung cancer. Eur Radiol 28(7):2772\u20132778. https:\/\/doi.org\/10.1007\/s00330-017-5221-1","journal-title":"Eur Radiol"},{"issue":"2","key":"4615_CR32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","volume":"295","author":"A Zwanenburg","year":"2020","unstructured":"Zwanenburg A et al (2020) The Image Biomarker Standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 295(2):328\u2013338. https:\/\/doi.org\/10.1148\/radiol.2020191145","journal-title":"Radiology"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04615-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-04615-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04615-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T17:34:50Z","timestamp":1690479290000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-04615-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["4615"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-04615-3","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"type":"print","value":"0171-5216"},{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[2023,3,16]]},"assertion":[{"value":"29 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the institutional ethics committee of Zhejiang Cancer Hospital (approval code IRB-2022-111, 8 March 2022).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publish"}}]}}